Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- The FDA has approved GSK Plc's (NYSE:GSK) Boostrix vaccine during the third trimester of pregnancy to prevent whooping cough in infants younger than two months.
- "When the Boostrix vaccine is given during pregnancy, it boosts antibodies in the mother, which are transferred to the developing baby," the agency said.
- While the FDA's approval of Boostrix has always included its use during pregnancy to protect the vaccinated individual, the latest decision expands its use to help prevent pertussis, commonly known as whooping cough, in infants younger than two months.
- The agency first approved the vaccine in 2005 for adolescents ages 10 years through 18 as a single-dose shot to prevent tetanus, diphtheria, and whooping cough.
- According to the Centers for Disease Control and Prevention (CDC), 4.2% of the total cases of pertussis – a common respiratory disease – reported in the United States in 2021 were in infants younger than six months of age.
- Price Action: GSK shares are up 0.10% at $30.14 during the premarket session on the last check Monday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!